---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-008297"
form_type: "8-K"
ticker: "ELUT"
cik: "0001708527"
company_name: "ELUTIA INC."
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T04:00:40.810893+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Elutia prelim FY2024 net sales $24.4M, down 1% YoY; cardiovascular sales plunge 42%

## Summary
- Preliminary 2024 net sales $24.4M vs $24.7M in 2023, a 1% decline.
- Women's health sales grew 12% to $11.6M; device protection up 5% to $9.9M.
- Cardiovascular sales fell 42% to $2.9M, dragging overall results.
- Results are preliminary; final numbers subject to adjustment upon completion of year-end close.
- No further financial details provided; full 10-K to follow.

## SEC filing metadata
- accession: 0001104659-25-008297
- form_type: 8-K
- ticker: ELUT
- cik: 0001708527
- company_name: ELUTIA INC.
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 2.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708527/000110465925008297/0001104659-25-008297-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708527/000110465925008297/tm254968d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-008297
- JSON: https://secwatch.observer/filing/0001104659-25-008297.json
- Plain text: https://secwatch.observer/filing/0001104659-25-008297.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.